Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial

NCT04307329 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: Monalizumab
BIOLOGICAL: Trastuzumab

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]